Schizophrenia Genetics: Putting All the Pieces Together
- 1.3k Downloads
Schizophrenia is a major mental disorder characterized by a deep disruption of the thinking process and of emotional response. For many decades, genetics studies have yielded little success in identifying genetic factors responsible for the disease. However, with the recent breakthroughs in genome analysis technologies, the field of the genetics of schizophrenia has progressed a lot in the last years. Both common and rare variants have been successfully associated with the disease and a particular emphasis has been made on rare copy number variations. Recently, a new paradigm linking de novo mutations to the genetic mechanism of schizophrenia has been unravelled. The aim of this review is to discuss the most important genetic studies made in the field to give a general perspective of where to go in the future.
KeywordsSchizophrenia Genetics Genomics GWAS Genome-wide association study Sequencing Next-generation sequencing De novo CNV Copy number variation Linkage studies Psychiatric disorder Mental disorder
Conflicts of interest: S.L. Girard: none; P.A. Dion: none; G.A. Rouleau: none.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 2.Tienari P. Schizophrenia in Finnish male twins. In: Lader MH, editor. Studies of schizophrenia. 1975. pp. 29–35.Google Scholar
- 23.Steinberg S, Mors O, Borglum AD, et al. Expanding the range of ZNF804A variants conferring risk of psychosis. Mol Psychiatry. 2010;16(1):59–66.Google Scholar
- 25.Hill MJ, Jeffries AR, Dobson RJB, Price J, Bray NJ. Knockdown of the psychosis susceptibility gene ZNF804A alters expression of genes involved in cell adhesion. Hum Mol Genet. 2011;21(5):1018–24.Google Scholar
- 42.Ingason A, Rujescu D, Cichon S, et al. Copy number variations of chromosome 16p13.1 region associated with schizophrenia. Mol Psychiatry. 2009;16(1):17–25.Google Scholar
- 43.•• Craddock N, Hurles ME, Cardin N, et al. Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature. 2010;464(7289):713–20. This study made by the WTCCC shows that the common CNVs are unlikely to contribute significantly to disease as they are already tagged by the SNPs.PubMedCrossRefGoogle Scholar
- 45.• Gauthier J, Champagne N, Lafreniere RG, et al. De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc Natl Acad Sci U S A. 2010;107(17):7863–8. This is the first study to report a de novo mutation in a gene and to associate this gene with the disease.PubMedCrossRefGoogle Scholar
- 47.Gauthier J, Siddiqui TJ, Huashan P, et al. Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. Hum Genet. 2011;130(4):563–73.Google Scholar
- 49.•• Girard SL, Gauthier J, Noreau A, et al. Increased exonic de novo mutation rate in individuals with schizophrenia. Nat Genet. 2011;43(9):860–3. This study has shown a higher than expected rate of de novo mutation as well as identified a strong enrichment in de novo truncating mutations.PubMedCrossRefGoogle Scholar
- 50.•• Xu B, Roos JL, Dexheimer P, et al. Exome sequencing supports a de novo mutational paradigm for schizophrenia. Nat Genet. 2011;43(9):864–8. This study has shown a higher than expected rate of de novo mutation as well as identified a strong enrichment in nonsynonymous mutations.PubMedCrossRefGoogle Scholar